These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 621720)

  • 1. Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
    Kokosa JM; Sinsheimer JE; Wade DR; Drach JC; Burckhalter JH
    J Med Chem; 1978 Feb; 21(2):225-8. PubMed ID: 621720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic formation and synthesis of 1-(3-chlorophenyl)-2(4-hydroxyphenyl)-1-methyl-2(2 pyridine)ethanol. A potential hypocholesteremic agent.
    Sinsheimer JE; Van den Eeckhout E; Hewitt LE; Kido Y; Wade DR; Hansen DW; Drach JC; Burckhalter JH
    J Med Chem; 1976 May; 19(5):647-50. PubMed ID: 1271406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-(2-Pyridine)benzyl aryl ketones as potential hypocholesteremic agents.
    Hewitt LE; Wade DR; Sinsheimer JE; Wang JH; Drach JC; Burckhalter JH
    J Med Chem; 1978 Dec; 21(12):1339-40. PubMed ID: 722749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesteremic agents. I. Substituted stilbazoles and dihydrostilbazoles.
    Villani FJ; Ellis CA; Tavares RF; Steinberg M; Tolksdorf S
    J Med Chem; 1970 May; 13(3):359-66. PubMed ID: 5459028
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of hepatic lipid biosynthesis by 1-(3-chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine) ethanol, a hypocholesterolemic agent.
    Ishidate K; Drach JC; Sinsheimer JE; Burckhalter JH
    Biochem Pharmacol; 1980 Dec; 29(23):3207-10. PubMed ID: 7447958
    [No Abstract]   [Full Text] [Related]  

  • 6. SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL 6-PHENYL-1H-PYRROLO[3,4-c]PYRIDINE-1,3-DIONE DERIVATIVES.
    Wojcicka A; Becan L; Junka A; Brtoszewicz M; Secewicz A; Trynda J; Wietrzyk J
    Acta Pol Pharm; 2017 Mar; 74(2):435-443. PubMed ID: 29624249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A theoretical study on supramolecularly-caged positively charged iridium(III) 2-pyridyl azolate derivatives as blue emitters for light-emitting electrochemical cells.
    Qu X; Liu Y; Si Y; Wu X; Wu Z
    Dalton Trans; 2014 Jan; 43(3):1246-60. PubMed ID: 24177725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antioxidant activity of new pyridines containing gallate moieties.
    El-Ebiary NM; Swellem RH; Mossa AT; Nawwar GA
    Arch Pharm (Weinheim); 2010 Sep; 343(9):528-34. PubMed ID: 20812226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential hypocholesteremic derivatives of styrylacetic acid II: cis- and trans-3-methyl-4-phenyl-3-butenoic acid analogs.
    Stratford ES; Smith LM; Tomecko GW
    J Pharm Sci; 1978 Jan; 67(1):80-3. PubMed ID: 563441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Synthesis of Novel Pyridine-Based Derivatives via Suzuki Cross-Coupling Reaction of Commercially Available 5-Bromo-2-methylpyridin-3-amine: Quantum Mechanical Investigations and Biological Activities.
    Ahmad G; Rasool N; Ikram HM; Gul Khan S; Mahmood T; Ayub K; Zubair M; Al-Zahrani E; Ali Rana U; Akhtar MN; Alitheen NB
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28134790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isostructural dinuclear phenoxo-/acetato-bridged manganese(II), cobalt(II), and zinc(II) complexes with labile sites: kinetics of transesterification of 2-hydroxypropyl-p-nitrophenylphosphate.
    Arora H; Barman SK; Lloret F; Mukherjee R
    Inorg Chem; 2012 May; 51(10):5539-53. PubMed ID: 22536852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
    Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
    Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxylamine metabolism in rat and monkey.
    Ganes DA; Hindmarsh KW; Midha KK
    Xenobiotica; 1986 Sep; 16(9):781-94. PubMed ID: 3765658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents.
    Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES
    Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.
    Leal B; Afonso IF; Rodrigues CR; Abreu PA; Garrett R; Pinheiro LC; Azevedo AR; Borges JC; Vegi PF; Santos CC; da Silveira FC; Cabral LM; Frugulhetti IC; Bernardino AM; Santos DO; Castro HC
    Bioorg Med Chem; 2008 Sep; 16(17):8196-204. PubMed ID: 18701299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of fluorine-18-labeled 5-HT1A antagonists.
    Lang L; Jagoda E; Schmall B; Vuong BK; Adams HR; Nelson DL; Carson RE; Eckelman WC
    J Med Chem; 1999 May; 42(9):1576-86. PubMed ID: 10229627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and dihydropteridine reductase inhibitory effects of potential metabolites of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Gessner W; Brossi A; Shen R; Abell CW
    J Med Chem; 1985 Mar; 28(3):311-7. PubMed ID: 3871859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agent.
    Wright JL; Downing DM; Feng MR; Hayes RN; Heffner TG; MacKenzie RG; Meltzer LT; Pugsley TA; Wise LD
    J Med Chem; 1995 Dec; 38(26):5007-14. PubMed ID: 8544176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of molecular modification on hypocholesteremic activity of 1,3-bis(substituted phenoxy)-2-propanones and related derivatives.
    Wyrick SD; Piantadosi C
    J Med Chem; 1978 Apr; 21(4):386-90. PubMed ID: 650666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some 4-thiazoline and 4H-1,2,4-triazole derivatives of imidazo[1,2-a]pyridine as possible anticonvulsants.
    Cesur N; Cesur Z
    Farmaco; 1994 Oct; 49(10):679-81. PubMed ID: 7826478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.